Antibodies News and Research

RSS

Immunocompromised patients show prolonged SARS-CoV-2 infection and unique mutations

study identifies risk factors for prolonged SARS-CoV-2 infection in immunocompromised patients, revealing that B-cell dysfunction, solid organ transplantation, and AIDS lead to longer infections and unique spike mutations.

31 Jan 2024

New DNA-based vaccine can induce strong antibody response against SARS-CoV-2

Using a virus-like delivery particle made from DNA, researchers from MIT and the Ragon Institute of MGH, MIT, and Harvard have created a vaccine that can induce a strong antibody response against SARS-CoV-2.

30 Jan 2024

Blood chip could offer early insights into cancer treatment effectiveness

Using a chip to process blood samples, doctors can monitor the amount of cancer cells in a patient’s blood to determine how well a treatment is working by the fourth week, according to a new University of Michigan study.

29 Jan 2024

Study offers insights into who's at risk for long COVID among immunocompromised patients

Early in the pandemic, clinicians noticed that certain immunocompromised patients were experiencing persistent SARS-CoV-2 infections, some lasting weeks to months at a time.

26 Jan 2024

Lunaphore and Acd Revolutionize Spatial Biology Research With the Launch of the First Fully Automated, Same-Section, Hyperplex Multiomics Application

Bio-Techne Corporation (NASDAQ: TECH) today announced that its spatial biology brands, Lunaphore and Advanced Cell Diagnostics (ACD), will launch the first fully automated spatial multiomics workflow with same-section hyperplex detection of RNA and protein biomarkers.

From Bio-Techne 25 Jan 2024

Do yellow fever vaccines truly provide effective lifelong protection against the disease after a single dose?

The long-term protection offered by one dose of vaccine against yellow fever.

25 Jan 2024

Maternal COVID-19 vaccination equally benefits preterm and full-term babies

A study in JAMA Network Open reveals that maternal COVID-19 vaccination provides similar antibody levels in preterm and full-term infants' cord blood, with higher doses leading to increased antibodies.

24 Jan 2024

Tulane scientists uncover key player in COVID's cell attachment

When SARS-CoV-2 enters the human body, the virus' spike protein binds to a cell, allowing the virus to infiltrate and begin replicating.

24 Jan 2024

Immune component of breast milk shapes the gut environment of infant mice

An immune component of breast milk known as the complement system shapes the gut environment of infant mice in ways that make them less susceptible to certain disease-causing bacteria, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

24 Jan 2024

Study finds three times the risk of respiratory distress in infants born to COVID-infected mothers

New UCLA-led research finds that infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed infants, even though they themselves were not infected with the virus.

24 Jan 2024

Turning senescent tumor cells into targets for better cancer treatment

Cancer treatments, including chemotherapy, in addition to killing a large number of tumor cells, also result in the generation of senescent tumor cells (also called "zombi cells").

24 Jan 2024

Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases

Oxitope Pharma (Oxitope) and Arxx Therapeutics (Arxx), companies with a shared goal of leveraging the innate immune system to discover and develop disease modulating therapies, today announced their merger to form Calluna Pharma Inc. (Calluna).

From Calluna Pharma 24 Jan 2024

New workflow identifies shared cancer targets, advancing immunotherapy

Researchers developed the Splicing Neo Antigen Finder (SNAF) workflow, integrating deep learning to identify shared immunogenic neoantigens in cancers, offering new targets for cancer immunotherapy, particularly in melanoma and ovarian cancer.

23 Jan 2024

Is a gluten-free diet always the healthier choice for women?

Study evaluates the impact of gluten-free diets on women's health, revealing benefits for specific gluten-related disorders but cautioning against unnecessary dietary restrictions.

23 Jan 2024

New technique helps track the brain's "off switches"

For decades, scientists have studied the intricate activity patterns in human and animal brains by observing when different groups of brain cells turn on.

23 Jan 2024

Study finds patients with long COVID exhibit complement dysregulation with signs of thromboinflammation

Researchers explore inflammatory signatures restricted to patients with active post-acute COVID-19 sequelae.

23 Jan 2024

Body mass index found to mediate causal associations between Helicobacter pylori infections and coronary artery disease risk

Coronary heart disease (CHD) and H. Pylori.

23 Jan 2024

Monoclonal antibodies for Alzheimer's offer little benefit, raise safety concerns

Researchers performed a meta-analysis of randomized trial studies that compared the use of amyloid-reducing monoclonal antibodies (MABs) in patients with Alzheimer's dementia at a dose consistent with that used in Phase 3 or FDA approval trials with the use of a placebo.

22 Jan 2024

New biomarkers could help detect lupus nephritis earlier

New biomarkers with improved diagnostic performance for early detection of lupus nephritis have been discovered in the University of Houston lab of Chandra Mohan, a pioneer in lupus research.

22 Jan 2024

Scientists demonstrate way to produce SARS-CoV-2 receptor protein in mouse cells

A team of scientists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory and Columbia University has demonstrated a way to produce large quantities of the receptor that SARS-CoV-2, the virus that causes COVID-19, binds to on the surface of human cells.

22 Jan 2024

Antibodies News and Research

Immunocompromised patients show prolonged SARS-CoV-2 infection and unique mutations

New DNA-based vaccine can induce strong antibody response against SARS-CoV-2

Blood chip could offer early insights into cancer treatment effectiveness

Study offers insights into who's at risk for long COVID among immunocompromised patients

Lunaphore and Acd Revolutionize Spatial Biology Research With the Launch of the First Fully Automated, Same-Section, Hyperplex Multiomics Application

Do yellow fever vaccines truly provide effective lifelong protection against the disease after a single dose?

Maternal COVID-19 vaccination equally benefits preterm and full-term babies

Tulane scientists uncover key player in COVID's cell attachment

Immune component of breast milk shapes the gut environment of infant mice

Study finds three times the risk of respiratory distress in infants born to COVID-infected mothers

Turning senescent tumor cells into targets for better cancer treatment

Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases

New workflow identifies shared cancer targets, advancing immunotherapy

Is a gluten-free diet always the healthier choice for women?

New technique helps track the brain's "off switches"

Study finds patients with long COVID exhibit complement dysregulation with signs of thromboinflammation

Body mass index found to mediate causal associations between Helicobacter pylori infections and coronary artery disease risk

Monoclonal antibodies for Alzheimer's offer little benefit, raise safety concerns

New biomarkers could help detect lupus nephritis earlier

Scientists demonstrate way to produce SARS-CoV-2 receptor protein in mouse cells

Antibodies eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News